- Home
- APVO vs XWEL Comparison
APVO vs XWEL Comparison
Compare APVO & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- XWEL
- Stock Information
- Founded
- APVO 2016
- XWEL 2006
- Country
- APVO United States
- XWEL United States
- Employees
- APVO N/A
- XWEL N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- APVO Health Care
- XWEL Consumer Discretionary
- Exchange
- APVO Nasdaq
- XWEL Nasdaq
- Market Cap
- APVO 4.1M
- XWEL 4.7M
- IPO Year
- APVO N/A
- XWEL N/A
- Fundamental
- Price
- APVO $3.06
- XWEL $1.12
- Analyst Decision
- APVO Strong Buy
- XWEL
- Analyst Count
- APVO 1
- XWEL 0
- Target Price
- APVO $5,920.00
- XWEL N/A
- AVG Volume (30 Days)
- APVO 191.0K
- XWEL 38.9K
- Earning Date
- APVO 08-07-2025
- XWEL 08-13-2025
- Dividend Yield
- APVO N/A
- XWEL N/A
- EPS Growth
- APVO N/A
- XWEL N/A
- EPS
- APVO N/A
- XWEL N/A
- Revenue
- APVO N/A
- XWEL $32,194,000.00
- Revenue This Year
- APVO N/A
- XWEL N/A
- Revenue Next Year
- APVO N/A
- XWEL N/A
- P/E Ratio
- APVO N/A
- XWEL N/A
- Revenue Growth
- APVO N/A
- XWEL 1.33
- 52 Week Low
- APVO $2.81
- XWEL $0.70
- 52 Week High
- APVO $381.10
- XWEL $2.42
- Technical
- Relative Strength Index (RSI)
- APVO 38.28
- XWEL 56.23
- Support Level
- APVO $3.01
- XWEL $0.90
- Resistance Level
- APVO $3.18
- XWEL $1.42
- Average True Range (ATR)
- APVO 0.16
- XWEL 0.09
- MACD
- APVO 0.19
- XWEL 0.02
- Stochastic Oscillator
- APVO 45.45
- XWEL 42.31
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.